- Strong global deployment across chest and stroke
- Concentrates on radiology depth over broad coverage
- Scales to organization-wide healthcare rollouts
Qure.ai
Global chest, CT, and stroke imaging AI
SF8.1
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Triage screening exams at scaleHospitals and global health programs
Triage screening exams at scaleHospitals and global health programs
Best for
Hospitals and global health programs
Pricing
Custom
SoftFinders Score
8.1 / 10
Overview
What is Qure.ai?
Qure.ai is an AI imaging company offering chest X-ray, CT, and stroke tools that flag findings to support clinicians across global markets. The product is positioned around imaging triage, finding prioritization, and radiologist productivity rather than autonomous interpretation, and regulatory clearance scope and validation depth vary by clinical indication. Buyers should confirm clearance details, integration with PACS and worklist tools, and impact metrics for the specific reading workflow being supported.
Qure.ai is aimed at hospitals and global health programs, and its main draw is strong global deployment across chest and stroke. The main caveat to weigh: clearance and reimbursement vary by market. Pricing is sales-led and scoped per buyer rather than posted publicly. Confirm scope, integration plan, and clinical review process before adoption.
KEY FEATURES
What you get out of the box
Worklist Integration
Integrates flagged studies into radiologist worklist
Multi Modality
Supports CT, MRI, X-ray, and related modalities
Care Coordination
Routes alerts to relevant care team members
Reporting Support
Drafts or supports impressions and report language
Imaging Workflow
Connects across PACS and reading environments
Outcome Tracking
Tracks downstream care actions from flagged studies
USE CASES
Where teams put it to work
Triage screening exams at scale
Reduce missed findings on busy lists
Bridge imaging and downstream pathways
Track outcomes from flagged studies
Standardize follow-up recommendations
Prioritize critical findings on imaging
Editorial Take
What we like, and what to verify
- Clearance and reimbursement vary by market
- Radiologist confirmation required on every study
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Gleamer SF 8
Why consider it
Broad X-ray AI suite for radiology
RapidAI SF 8
Why consider it
Stroke and vascular imaging triage platform
Subtle Medical SF 7.7
Why consider it
AI image enhancement for MRI and PET
Imagen Technologies SF 7.5
Why consider it
AI-supported radiology reads and workflow
Riverain Technologies SF 7.4
Why consider it
Chest and lung X-ray detection AI
Nanox.AI SF 7.6
Why consider it
Chronic disease detection on routine CT
FAQ